Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$728M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$645M |
| 3 |
SPDR Gold Trust
GLD
|
+$413M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$401M |
| 5 |
SpaceX
SPCX
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.91B |
| 2 |
Micron Technology
MU
|
+$1.85B |
| 3 |
NVIDIA
NVDA
|
+$1.69B |
| 4 |
GE Vernova
GEV
|
+$809M |
| 5 |
Advanced Micro Devices
AMD
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.44% |
| 2 | Technology | 22.37% |
| 3 | Financials | 6.09% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Healthcare | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Dimensional Global Real Estate ETF
DFGR
$4.04B
| $1.24M | ﹤0.01% |
45,659
+1,931
| +4% | +$56.1K |
2024 Q3
8 quarters
|
|
3102
Schwab US Broad Market ETF
SCHB
$44.8B
| $1.23M | ﹤0.01% |
42,133
+3,492
| +9% | +$102K |
2013 Q2
53 quarters
|
|
3103
Southern Missouri Bancorp
SMBC
$799M
| $1.23M | ﹤0.01% |
17,413
-765
| -4% | -$57.4K |
2016 Q2
41 quarters
|
|
3104
Vanguard Russell 3000 ETF
VTHR
$4.91B
| $1.23M | ﹤0.01% |
+3,674
| New | +$1.23M |
2026 Q3
0 quarters
|
|
3105
PUT
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.52B
| $1.23M | ﹤0.01% |
30,000
| – | – |
2026 Q1
2 quarters
|
|
3106
Tutor Perini Cor
TPC
$4.37B
| $1.23M | ﹤0.01% |
14,857
-19,332
| -57% | -$1.66M |
2013 Q2
53 quarters
|
|
3107
Dimensional International Vector Equity ETF
DXIV
$234M
| $1.22M | ﹤0.01% |
17,010
+625
| +4% | +$45.6K |
2026 Q2
1 quarter
|
|
3108
Eton Pharmaceutcials
ETON
$1.45B
| $1.22M | ﹤0.01% |
23,756
+2,804
| +13% | +$142K |
2024 Q3
8 quarters
|
|
3109
CALL
Charter Communications
CHTR
$13.8B
| $1.22M | ﹤0.01% |
11,000
-58,600
| -84% | -$8.16M |
2025 Q3
4 quarters
|
|
3110
CALL
Applied Digital
APLD
$5.02B
| $1.22M | ﹤0.01% |
+50,000
| New | +$1.4M |
2026 Q3
0 quarters
|
|
3111
Ballard Power Systems
BLDP
$558M
| $1.22M | ﹤0.01% |
600,529
+561,163
| +1,426% | +$1.44M |
2018 Q3
32 quarters
|
|
3112
Sotera Health
SHC
$4.68B
| $1.22M | ﹤0.01% |
65,842
-63,067
| -49% | -$1.16M |
2020 Q4
23 quarters
|
|
3113
CALL
Amer Sports
AS
$18.6B
| $1.21M | ﹤0.01% |
44,500
-412,400
| -90% | -$13.2M |
2026 Q2
1 quarter
|
|
3114
PUT
Liquidia Corp
LQDA
$4.24B
| $1.21M | ﹤0.01% |
40,000
| – | – |
2026 Q1
2 quarters
|
|
3115
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.05B
| $1.21M | ﹤0.01% |
13,040
-306,206
| -96% | -$29.2M |
2013 Q2
53 quarters
|
|
3116
ONE Gas
OGS
$5.17B
| $1.21M | ﹤0.01% |
16,816
-42,954
| -72% | -$3.36M |
2014 Q1
50 quarters
|
|
3117
Palvella Therapeutics
PVLA
$2.34B
| $1.21M | ﹤0.01% |
8,745
-6,748
| -44% | -$1M |
2017 Q2
37 quarters
|
|
3118
Vanguard ESG US Stock ETF
ESGV
$13.4B
| $1.2M | ﹤0.01% |
8,871
-21,656
| -71% | -$2.91M |
2019 Q4
27 quarters
|
|
3119
Hawaiian Electric Industries
HE
$1.47B
| $1.2M | ﹤0.01% |
134,279
-300,065
| -69% | -$3.54M |
2013 Q2
53 quarters
|
|
3120
Benchmark Electronics
BHE
$2.33B
| $1.2M | ﹤0.01% |
14,426
-6,714
| -32% | -$530K |
2013 Q2
53 quarters
|
|
3121
Celldex Therapeutics
CLDX
$2.35B
| $1.2M | ﹤0.01% |
36,901
-367,802
| -91% | -$14.1M |
2020 Q4
23 quarters
|
|
3122
Bio-Rad Laboratories Class A
BIO
$10.2B
| $1.19M | ﹤0.01% |
3,150
-1,906
| -38% | -$665K |
2013 Q2
53 quarters
|
|
3123
CALL
Cytokinetics
CYTK
$8.84B
| $1.19M | ﹤0.01% |
18,000
-38,000
| -68% | -$2.9M |
2024 Q2
9 quarters
|
|
|
3124
PUT
Cytokinetics
CYTK
$8.84B
| $1.19M | ﹤0.01% |
+18,000
| New | +$1.37M |
2026 Q3
0 quarters
|
|
3125
Andersons Inc
ANDE
$1.88B
| $1.18M | ﹤0.01% |
17,954
-4,788
| -21% | -$335K |
2013 Q2
53 quarters
|
|
Similar funds
Citigroup's Q3 2026 Portfolio in Review
As of Q3 2026, Citigroup held 6,419 positions worth $308B, up 1.8% from $303B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2026 filing shows 741 new, 2,043 increased, 2,737 reduced and 437 closed positions. Its largest new stake was SK Hynix Inc: 1,085,406 shares worth $200M. The largest sale was Microsoft, an estimated $1.91B.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q3 2026 buy was SK Hynix Inc: 1,085,406 shares worth $200M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $728M increase.
- Citigroup's biggest Q3 2026 reduction was Microsoft, cutting an estimated $1.91B.
- Citigroup fully exited Webster Financial in Q3 2026, selling an estimated $273M.
- Citigroup's ten largest holdings make up 21% of its $308B portfolio in Q3 2026.
- Citigroup opened 741 new positions and closed 437 in Q3 2026.
- Citigroup's portfolio value rose 1.8% quarter-over-quarter to $308B.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.